Meclizine Hydrochloride

Manufacturer: DIRECT RX
Effective date: 2023-04-12
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-05-31 20:48:23

Label at a glance#

ProductMeclizine Hydrochloride

Active ingredientMECLIZINE HYDROCHLORIDE

Label structure11 sections

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Chemically, Meclizine HCl is 1-(p-chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate.

image description

Meclizine HCI Tablets, USP are available in two different strengths: 12.5 mg and 25 mg. In addition each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose. Also, Meclizine HCI Tablets USP, 12.5 mg contains FD&C Blue #1 Aluminum Lake (11-13%) and Meclizine HCI Tablets USP, 25 mg contains D&C Yellow #10 Aluminum Lake (15-20%).

CLINICAL PHARMACOLOGY SECTION

Meclizine Hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

INDICATIONS & USAGE SECTION

Meclizine Hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it

CONTRAINDICATIONS SECTION

Meclizine Hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it

WARNINGS SECTION

Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery.

Patients should avoid alcoholic beverages while taking this drug.

Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma or enlargement of the prostate gland.

PRECAUTIONS SECTION

PREGNANCY, Teratogenic Effects
Pregnancy Category B. Reproduction studies in rats have shown cleft palates at 25-50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that medicine increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, meclizine, or any other medication, should be used during pregnancy only if clearly necessary.

Pediatric Use
Clinical studies establishing safety and effectiveness in children have not been done; therefore, usage is not recommended in children under 12 years of age.

ADVERSE REACTIONS SECTION

Drowsiness, dry mouth and, on rare occasions, blurred vision have been reported.

DOSAGE & ADMINISTRATION SECTION

Motion Sickness
The initial dose of 25 to 50 mg of Meclizine HCI should be taken one hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

HOW SUPPLIED SECTION

Meclizine HCI Tablets, USP are available in the following strengths and package sizes:

12.5 mg (Blue, oval-shaped, scored, debossed with TL122)

Bottles of 100           NDC 59746-122-06
Bottles of 1000         NDC 59746-122-10

25 mg (Yellow, oval-shaped, scored, debossed with TL121)

Bottles of 100            NDC 59746-121-06
Bottles of 1000          NDC 59746-121-10

Store at 20-25°C (68-77°F) (See USP Controlled Room Temperature].

Manufactured By:

Jubilant Cadista Pharmaceuticals Inc.
Salisbury, MD 21801, USA.

Revised 03/11

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

146-30

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
995666	meclizine HCl 25 MG Oral Tablet	PSN	9
995666	meclizine hydrochloride 25 MG Oral Tablet	SCD	9

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
MECLIZINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ac6963c4-31c6-325f-ee58-83a0a06597ad	Product name	5	20221206

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-146-20	2025-01-30	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride
61919-146-30	2025-01-30	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride
61919-146-20	2021-01-07	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride
61919-146-30	2021-01-07	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride
61919-146-20	2020-01-31	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride
61919-146-30	2020-01-31	C162847	48780-1	9d75b9d0-09f7-f424-e053-dadaa90a57ce	Meclizine Hydrochloride

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-146-20	Meclizine Hydrochloride	20 in 1 BOTTLE	TABLET	20		9
61919-146-30	Meclizine Hydrochloride	30 in 1 BOTTLE	TABLET	30		9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-146	MECLIZINE HYDROCHLORIDE TABLET [DIRECT RX]	9	Legacy NDC, 2 package rows	20230413_648570f0-2def-4d15-87bc-ca631439e7f4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-146-10	EA - Each	61919-146	19ad8fca-5b76-4a18-9b9e-d2ed186be04b	1	2019-09-05
61919-146-20	EA - Each	61919-146	991ce28a-76c3-41be-81f6-49412476ed62	1	2014-06-03
61919-146-30	EA - Each	61919-146	4749e47b-9dea-4085-8939-78927a77bfbb	1	2015-10-02
61919-146-90	EA - Each	61919-146	5ddd56ad-2296-467a-b971-0fed970fad99	1	2019-09-05
59746-121-06	EA - Each	59746-121	426b1544-2026-4b5e-92b6-b06bf4ad8883	1	2012-07-24
59746-121-10	EA - Each	59746-121	ef373495-c09a-4243-9246-5944249609e5	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Meclizine Hydrochloride	ACTIVE INGREDIENT	HDP7W44CIO	2
MECLIZINE	ACTIVE MOIETY	3L5TQ84570	2
Aluminum Oxide	INACTIVE INGREDIENT	LMI26O6933	2
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	2
Croscarmellose Sodium	INACTIVE INGREDIENT	M28OL1HH48	2
Fd&c Blue No. 1	INACTIVE INGREDIENT	H3R47K3TBD	2
Lactose Monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	2
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	2
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Meclizine Hydrochloride
CROSCARMELLOSE SODIUM
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
FD&C BLUE NO. 1
ALUMINUM OXIDE
MECLIZINE
SILICON DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
61919-146	61919-146-20, 61919-146-30
59746-121

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
ALUMINUM OXIDE	LMI26O6933	IACT
MECLIZINE HYDROCHLORIDE	HDP7W44CIO	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 215 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE / ORAL		2169 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / RESPIRATORY (INHALATION)		50 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	47.5 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / ORAL	1.13 mg/15ml		Exact identifier — unii candidate 37 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	FILM, SOLUBLE / ORAL	0.04 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 37 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, DELAYED RELEASE / ORAL		366 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE / ORAL	26.3 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SHAMPOO / TOPICAL	0.75 %w/w		Exact identifier — unii candidate 37 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, DELAYED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	PELLET / ORAL		1140 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PASTE / DENTAL	34 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SOLUTION / ORAL		690 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, COATED / ORAL		1301 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	PELLET / ORAL		162 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED / ORAL		992 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL		750 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / ORAL		300 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	GRANULE / ORAL		150 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Cellulose, Microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, EXTENDED RELEASE / ORAL		5119 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	TROCHE / ORAL		50 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SUSPENSION / ORAL		1 mg	Exact identifier — unii candidate 37 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	690 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	CAPSULE, COATED / ORAL		300 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, EXTENDED RELEASE / ORAL		2575 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE / ORAL	5000 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / VAGINAL	8 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		520 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS		214 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, ORALLY DISINTEGRATING / ORAL		366 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET / ORAL		4384 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	GRANULE, FOR SUSPENSION / ORAL		282 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Croscarmellose Sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	CAPSULE, DELAYED RELEASE / ORAL		72 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	PELLET / ORAL		640 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, COATED / ORAL		184 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION / INTRAMUSCULAR		150 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	TABLET / ORAL	27.53 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, FOR SUSPENSION / ORAL		2794 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose Monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
Fd&c Blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	LIQUID / ORAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SYSTEM / TRANSDERMAL		35 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / TOPICAL		6 mg	Exact identifier — unii candidate 49 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040659-001	MECLIZINE HYDROCHLORIDE	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA		2010-06-04
A040659-002	MECLIZINE HYDROCHLORIDE	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA		2010-06-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A040659-001	AA
A040659-002	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 90 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-11-14 07:37:17	2026-10	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`d4dbc9d85df4…`
2026-10-15 13:18:30	2026-09	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040659-001	MECLIZINE HYDROCHLORIDE	12.5MG	TABLET / ORAL	AA	2010-06-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A040659-002	MECLIZINE HYDROCHLORIDE	25MG	TABLET / ORAL	AA	2010-06-04	`5d02ea3f76ae…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 90 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-11-14 07:37:17	2026-10	A040659-001	AA	1	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A040659-002	AA	1	`d4dbc9d85df4…`
2026-10-15 13:18:30	2026-09	A040659-001	AA	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A040659-002	AA	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A040659-001	AA	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A040659-002	AA	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A040659-001	AA	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040659-002	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040659-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040659-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040659-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040659-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040659-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040659-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040659-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040659-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040659-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040659-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040659-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040659-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040659-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040659-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040659-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040659-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040659-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040659-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040659-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040659-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040659-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040659-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040659-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040659-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040659-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040659-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040659-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A040659-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040659-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040659-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040659-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A040659-002	AA	1	`5d02ea3f76ae…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
f9297a30-a8e5-2461-e053-6294a90a3a25			648570f0-2def-4d15-87bc-ca631439e7f4	2023-04-12	Warnings, Adverse reactions	Exact identifier spl id: f9297a30-a8e5-2461-e053-6294a90a3a25 spl set id: 648570f0-2def-4d15-87bc-ca631439e7f4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.